| abstract |
The present disclosure relates to a compound of formula (I), or a compound of formula (IA), (IB) or (IC), or a solvate thereof, for a person in need thereof for the treatment or prevention of an insomnia disorder. It relates to a method performed by administering at a daily dose of 0.5 mg to about 6.0 mg. In certain embodiments, such compounds effectively treat or prevent insomnia disorders in animals with reduced side effects compared to previously available compounds. [Chemical 1] [Selection diagram] None |